Therefore, the heterozygous model is particularly suitable for future studies to gain a deeper understanding of the dosage effect of the partial loss of ABCC6 in PXE, representing carriers of a heterozygous hABCC6 mutation which often shows a milder phenotype [44]. This evidence concerns the gene ABCC6 and pseudoxanthoma elasticum (inherited or acquired).